Lalitha Biswas

Lalitha Biswas

Auto-generated profile, based on publicly available information

Lalitha Biswas

Amrita School of Nanosciences and Molecular Medicine Amrita Vishwa Vidyapeetham Kochi Kerala India

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in International Journal of Medical Microbiology
Verified
Journal Article
Closed access
MSManeesha K. Suresh
Maneesha K. Suresh
RBRaja Biswas
Raja Biswas
LBLalitha Biswas
Lalitha Biswas

1 June 2014 in Infection and Immunity
Verified
Journal Article
Open access
PDF file
NNNisha Nair
Nisha Nair
RBRaja Biswas
Raja Biswas
FGFriedrich Götz
Friedrich Götz
LBLalitha Biswas
Lalitha Biswas
Polymicrobial infections involvingStaphylococcus aureusexhibit enhanced disease severity and morbidity. We reviewed the nature of polymicrobial interactions betweenS. aureusand other bacterial, fungal, and viral cocolonizers. Microbes that were frequently recovered from the infection site withS. aureusareHaemophilus influenzae,Enterococcus faecalis,Pseudomonas aeruginosa,Streptococcus pneumoniae,Corynebacteriumsp.,Lactobacillussp.,Candida albicans, and influenza virus. Detailed analyses of severalin vitroandin vivoobservations demonstrate thatS. aureusexhibits cooperative relations withC. albicans,E. faecalis,H. influenzae, and influenza virus and competitive relations withP. aeruginosa,Streptococcus pneumoniae,Lactobacillussp., andCorynebacteriumsp. Interactions of both types influence changes inS. aureusthat alter its characteristics in terms of colony formation, protein expression, pathogenicity, and antibiotic susceptibility.

1 June 2009 in The Journal of Immunology
Verified
Journal Article
Open access
MSMathias Schmaler
Mathias Schmaler
NJNaja J Jann
Naja J Jann
FFFabrizia Ferracin
Fabrizia Ferracin
LLLea Z Landolt
Lea Z Landolt
LBLalitha Biswas
Lalitha Biswas
RLRegine Landmann
Regine Landmann
Lipoproteins (Lpp) are ligands of TLR2 and signal by the adaptor MyD88. As part of the bacterial cell envelope, Lpp are mainly involved in nutrient acquisition for Staphylococcus aureus. The impact of Lpp on TLR2-MyD88 activation for S. aureus in systemic infection is unknown. S. aureus strain SA113 deficient in the enzyme encoded by the prolipoprotein diacylglyceryl transferase gene (Δlgt), which attaches the lipid anchor to pro-Lpp, was used to study benefits and costs of Lpp maturation. Lpp in S. aureus induced early and strong cytokines by TLR2-MyD88 signaling in murine peritoneal macrophages. Lpp contributed via TLR2 to pathogenesis of sepsis in C57BL/6 mice with IL-1β, chemokine-mediated inflammation, and high bacterial numbers. In the absence of MyD88-mediated inflammation, Lpp allowed bacterial clearing from liver devoid of infiltrating cells, but still conferred a strong growth advantage in mice, which was shown to rely on iron uptake and storage in vitro and in vivo. With iron-restricted bacteria, the Lpp-related growth advantage was evident in infection of MyD88−/−, but not of C57BL/6, mice. On the other hand, iron overload of the host restored the growth deficit of Δlgt in MyD88−/−, but not in immunocompetent C57BL/6 mice. These results indicate that iron acquisition is improved by Lpp of S. aureus but is counteracted by inflammation. Thus, lipid anchoring is an evolutionary advantage for S. aureus to retain essential proteins for better survival in infection.

31 December 2020 in Journal of Applied Microbiology
Verified
Journal Article
Open access
PDF file
JJJ. Jayakumar
J. Jayakumar
VKV.A. Kumar
V.A. Kumar
LBL. Biswas
L. Biswas
RBRaja Biswas
Raja Biswas
Staphylococcus aureus, an opportunistic pathogen, causes diverse community and nosocomial‐acquired human infections, including folliculitis, impetigo, sepsis, septic arthritis, endocarditis, osteomyelitis, implant‐associated biofilm infections and contagious mastitis in cattle. In recent days, both methicillin‐sensitive and methicillin‐resistant S. aureus infections have increased. Highly effective anti‐staphylococcal agents are urgently required. Lysostaphin is a 27 kDa zinc metallo antimicrobial lytic enzyme that is produced by Staphylococcus simulans biovar staphylolyticus and was first discovered in the 1960s. Lysostaphin is highly active against S. aureus strains irrespective of their drug‐resistant patterns with a minimum inhibitory concentration of ranges between 0·001 and 0·064 μg ml−1. Lysostaphin has activity against both dividing and non‐dividing S. aureus cells; and can seep through the extracellular matrix to kill the biofilm embedded S. aureus. In spite of having excellent anti‐staphylococcal activity, its clinical application is hindered because of its immunogenicity and reduced bio‐availability. Extensive research with lysostaphin lead to the development of several engineered lysostaphin derivatives with reduced immunogenicity and increased serum half‐life. Therapeutic efficacy of both native and engineered lysostaphin derivatives was studied by several research groups. This review provides an overview of the therapeutic applications of native and engineered lysostaphin derivatives developed to eradicate S. aureus infections.

3 November 2021 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
PDF file
PSParasmal Suresh
Parasmal Suresh
AKAnil Kumar
Anil Kumar
RBRaja Biswas
Raja Biswas
DVDivya Vijayakumar
Divya Vijayakumar
STSwathy Thulasidharan
Swathy Thulasidharan
LBLalitha Biswas
Lalitha Biswas
: Nontuberculosis mycobacteria (NTM) are opportunistic pathogens that cause a wide range of illnesses. Here, the species distribution and prevalence of NTM infections in tuberculosis suspects was analyzed. A total of 7,073 specimens from pulmonary and extrapulmonary sites were analyzed, and 709 (10%) were found to be culture positive for mycobacteria. Of these, 85.2% were identified as Mycobacterium tuberculosis complex and 14.8% as NTM (65.7% rapid growers and 34.3% slow growers). Speciation of the NTM isolates (n = 69) identified 19 NTM species. M. abscessus (33.3%) and M. fortuitum (24.6%) were the most dominant NTM species isolated from the patients, followed by M. porcinum (5.8%) and M. parascrofulaceum (4.3%). We also report peritonitis caused by rapidly growing NTM among the patients undergoing continuous ambulatory peritoneal dialysis and a case of M. senegalense peritonitis. A low prevalence but high species diversity of NTM was detected in our study. The high species diversity of NTM necessitates the need to unequivocally identify mycobacterial isolates for appropriate treatment.

14 April 2021 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
ASAlka Suresh
Alka Suresh
PSParasmal Suresh
Parasmal Suresh
RBRaja Biswas
Raja Biswas
ARAnupama Rajanbabu
Anupama Rajanbabu
SSSarala Sreedhar
Sarala Sreedhar
LBLalitha Biswas
Lalitha Biswas